| Metric | Q1'26 | Q2'26 | Change |
|---|---|---|---|
| Adjusted earnings (GAAP) | $1.6 bn, +18% YoY (Q1) | $1.6 bn, +15% YoY (Q2) | Growth slowed by 3 points YoY |
| Adjusted EPS | $2.42, +23% YoY (Q1) | $2.43, +20% YoY (Q2) | EPS growth decelerated |
| Net income | $1.1 bn (Q1) | $705 m (Q2) | Net income down ~36% |
| Variable investment income (pre‑tax) | $518 m (Q1) | $231 m (Q2) | Drop of 55% YoY |
| Direct expense ratio | 11.9% (Q1) | 12.1% (Q2) | Expense ratio worsened 20 bps |
| Group Benefits adjusted earnings | $439 m, +19% YoY (Q1) | $503 m, +25% YoY (Q2) | Growth acceleration |
| RIS adjusted earnings | $451 m, +11% YoY (Q1) | $377 m, +2% YoY (Q2) | Earnings slowdown |
| Asia adjusted earnings | $487 m, +31% YoY (Q1) | $420 m, +21% YoY (Q2) | Growth slowed |
| Cash & liquid assets | $3.9 bn (Q1) | $3.4 bn (Q2) | Cash buffer decreased 0.5 bn |
| Total AUM (MetLife Investment Management) | $748 bn (Q1) | $748 bn (Q2) | Flat |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.